High levels of susceptibility to new and older antibiotics in Neisseria gonorrhoeae isolates from Saskatchewan (2003-15): time to consider point-of-care or molecular testing for precision treatment?-authors' response

J Antimicrob Chemother. 2018 Mar 1;73(3):829-830. doi: 10.1093/jac/dkx512.

Authors

Sidharath D Thakur^{1

2}, Jo-Anne R Dillon^{1

2}

Affiliations

¹ Department of Microbiology and Immunology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
² Vaccine and Infectious Disease Organization - International Vaccine Centre (VIDO-InterVac), University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

PMID: 29360986
DOI: 10.1093/jac/dkx512

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents
Gonorrhea*
Humans
Neisseria gonorrhoeae*
Point-of-Care Systems
Saskatchewan

Substances

Anti-Bacterial Agents